Earnings Preview: Curaleaf Holdings, Inc. (CURLF) Q4 Earnings Expected to Decline
Curaleaf Holdings, Inc. (CURLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The U.S. Marijuana Stocks Gaining Attention in February 2026
The U.S. cannabis sector enters February 2026 in a period of transition. After years of volatility, the industry is becoming more disciplined. Many operators are now prioritizing profitability instead of rapid expansion. As a result, stronger companies are beginning to separate from weaker competitors.
Best U.S. Marijuana Stocks to Follow as February 2026 Begins
The U.S. cannabis sector enters February 2026 at a critical inflection point. Market sentiment has improved, yet investors remain selective. After several years of consolidation, attention is shifting toward operators with scale and execution. As a result, established multi-state operators continue drawing interest.
2 Leading Marijuana Stocks That Could Help Bring The Sector Up
Investing in the cannabis industry today is unlike any other sector in the stock market. In 2026, it blends pioneering regulatory shifts and volatile stock behavior. Along with the promise of long-term growth tied to broader acceptance of marijuana for medical and adult-use purposes. As you consider which marijuana stocks belong in your portfolio, it helps to understand how the cannabis market has evolved.
The Best Marijuana Stocks 2026 And What Investors Should Know
Most marijuana stock investors have gotten used to how the sector behaves in certain scenarios. For example, history has shown that political news on reform, mainly in the USA, leads to better trading. As well as news on a company strong enough to move the stock up becuase of it, like strong earnings or a strategic partnership. Right now, there is high speculation on what will occur in 2026. This year is another pivotal one, already bringing many changes to the cannabis industry as a whole.
Curaleaf Announces Delaware Domestication Plan: How to Play the Stock?
CURLF's Delaware domestication plan could streamline governance and enhance capital market flexibility as U.S. pressure persists and international growth builds.
Fight the Urge to Sell: 3 Stocks With Terrible Charts That Still Look Like Buying Opportunities If You're Patient Enough
I recently saw a social media post which stood out to me. This post was a long-term chart going back about 50 years, highlighting all the downturns over this time frame, and all the reasons investors had to sell at particular down points in the market.
Best Marijuana Stocks to Watch Right Now
The U.S. cannabis industry continues evolving in 2025. Investors are watching major multi-state operators closely as legalization debates continue. Many traders remain cautious after repeated sector pullbacks. However, long-term growth expectations still look strong. Because of this, investors are searching for companies with real revenue, strong national footprints, and disciplined expansion plans.
Why I'm Buying Curaleaf Before The 2026 Hemp Ban Kicks In
Curaleaf Holdings, Inc. stands to benefit from the impending federal ban on hemp-derived THC, potentially reversing price compression and boosting margins. CURLF trades at a significant discount to peers, with EV/sales at 2.18x and price/sales at 1.37x, despite strong cash flow and margin performance. International growth remains robust, compounding at 56% YoY, offering long-term upside as new markets mature.
2 Marijuana Stocks For Better Investing In 2026
Marijuana stock investors are awaiting the next jump in the market. More people are readjusting their strategies to prepare for this upcoming trading year. There is another push for a chance to federally legalize cannabis. When the campaign begins, shareholders will take better market action. History has shown that when federal reform news shows progression, it reflects well in the public sector for most pot stocks.
Curaleaf Holdings Shares Fell After Earnings, But It Leads The Cannabis Pack
Curaleaf Holdings, Inc. remains the leading cannabis company by market cap, despite ongoing EPS losses and post-earnings share volatility. CURLF's latest quarterly results beat revenue and EPS forecasts, but shares declined after the report, reflecting continued sector uncertainty. The stock's upside is tied to U.S. federal marijuana reform, particularly rescheduling or legalization, which could unlock explosive growth for CURLF.
Curaleaf Holdings, Inc. (CURLF) Reports Q3 Loss, Beats Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.07 per share a year ago.
